Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8037)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2015 (publication date) through Jun 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Malhotra N, Beaton MD. Management of non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7(30): 2962-2967 [PMID: 26730275 DOI: 10.4254/wjh.v7.i30.2962] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i30/2962.htm |
| Number | Citing Articles |
| 1 |
Elke Roeb, Ralf Weiskirchen. Fructose and Non-Alcoholic Steatohepatitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.634344
|
| 2 |
Fang Liu, Hui Zhou, Lei Cao, Zhirong Guo, Chen Dong, Lugang Yu, Yiying Wang, Chunxing Liu, Jing Qiu, Yong Xue, Xingxiang Liu, Yunfang Xu. Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0865-7
|
| 3 |
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Iranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
|
| 4 |
Yang Xia, Xuena Wang, Shunmin Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study. Nutrition Journal 2019; 18(1) doi: 10.1186/s12937-019-0502-y
|
| 5 |
Yang Xia, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease. Nutrition 2020; 71: 110562 doi: 10.1016/j.nut.2019.110562
|
| 6 |
Jessica Wisocky, Sonali Paul. The rising incidence of nonalcoholic fatty liver disease. The Nurse Practitioner 2017; 42(7): 14 doi: 10.1097/01.NPR.0000520420.17084.bb
|
| 7 |
Shahla Abdollahi-Roodsaz, Steven B. Abramson, Jose U. Scher. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nature Reviews Rheumatology 2016; 12(8): 446 doi: 10.1038/nrrheum.2016.68
|
| 8 |
Florian Simon, Christoph Antoni. Erhöhte Leberwerte – was nun?. MMW - Fortschritte der Medizin 2016; 158(S3): 66 doi: 10.1007/s15006-016-8610-5
|
| 9 |
Qian Wang, Hongkai Yan, Gang Wang, Zhaoyan Qiu, Bin Bai, Shiqi Wang, Pengfei Yu, Quanxin Feng, Qingchuan Zhao, Xianli He, Chaoxu Liu. RNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: a gene expression profiling comparative study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00821-5
|
| 10 |
Antonella Amato, Gaetano-Felice Caldara, Domenico Nuzzo, Sara Baldassano, Pasquale Picone, Manfredi Rizzo, Flavia Mulè, Marta Di Carlo. NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. Nutrients 2017; 9(5): 492 doi: 10.3390/nu9050492
|
| 11 |
A-Rang Im, Yun Hee Kim, Young Hwa Kim, Won-Kyung Yang, Seung Hyung Kim, Kwang Hoon Song. Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat Diets. Journal of Medicinal Food 2017; 20(12): 1222 doi: 10.1089/jmf.2017.4036
|
| 12 |
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
|
| 13 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
|
| 14 |
Nael Mohammed Sarheed, Haider Salih Jaffat. Detection of chemical compounds and its antioxidant activity of aniseeds extract. PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Conference of Al-Muthanna University/College of Science 2022; 2398: 040049 doi: 10.1063/5.0093811
|
| 15 |
Eun-Young Kwon, Ji-Won Kim, Ji-Young Choi. Effect of Prunella vulgaris var. lilacina Nakai Ethanol Extract (PVE) on Lipid Metabolism in the Livers of Mice Fed a High-fat Diet. The Korean Journal of Community Living Science 2021; 32(3): 451 doi: 10.7856/kjcls.2021.32.3.451
|
| 16 |
Asmaa M. Hamed, Omnyah A. El-Kharashi, Suzi S.A. Boctor, Lobna F. Abd-Elaziz. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD. Biomedicine & Pharmacotherapy 2017; 85: 68 doi: 10.1016/j.biopha.2016.11.114
|
| 17 |
Yu-Jie Zhou, Ji-Na Zheng, Wen-Yue Liu, Luca Miele, Alessandro Vitale, Sven Van Poucke, Tian-Tian Zou, Dan-Hong Fang, Shengrong Shen, Dong-Chu Zhang, Ming-Hua Zheng. The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver. Clinica Chimica Acta 2017; 468: 17 doi: 10.1016/j.cca.2017.01.021
|
| 18 |
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?. Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
|
| 19 |
Irmina Morawska, Andrzej Cieszanowski. Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging – a systematic review. Polish Journal of Radiology 2023; 88: 512 doi: 10.5114/pjr.2023.132884
|
| 20 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
|
| 21 |
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
|
| 22 |
Khalifa Mohammad Helal, James Nicholas Taylor, Harsono Cahyadi, Akira Okajima, Koji Tabata, Yoshito Itoh, Hideo Tanaka, Katsumasa Fujita, Yoshinori Harada, Tamiki Komatsuzaki. Raman spectroscopic histology using machine learning for nonalcoholic fatty liver disease. FEBS Letters 2019; 593(18): 2535 doi: 10.1002/1873-3468.13520
|
| 23 |
O. Ahmed, C. Pramfalk, M. Pedrelli, M. Olin, K.R. Steffensen, M. Eriksson, P. Parini. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice. Digestive and Liver Disease 2019; 51(7): 1016 doi: 10.1016/j.dld.2018.12.007
|
| 24 |
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
|
| 25 |
Somak Das, Sudeepta Kumar Swain, Pavan Kumar Addala, Ramakrishnan Balasubramaniam, C. V. Gopakumar, Dinesh Zirpe, Kirubakaran Renganathan, Harsha Kollu, Darshan Patel, Bipin B. Vibhute, Prashantha S. Rao, Elankumaran Krishnan, Mahesh Gopasetty, Anand K. Khakhar, Anil Vaidya, Anand Ramamurthy. Initial Poor Function and Primary Nonfunction in Deceased-Donor Orthotopic Liver Transplantation Maintaining Short Cold Ischemic Time. Progress in Transplantation 2016; 26(4): 340 doi: 10.1177/1526924816663516
|
| 26 |
V A Akhmedov, O V Gaus. Involvement of the hepatobiliary system and pancreas in obesity. Terapevticheskii arkhiv 2017; 89(1): 128 doi: 10.17116/terarkh2017891128-133
|
| 27 |
Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. PLOS ONE 2017; 12(4): e0173376 doi: 10.1371/journal.pone.0173376
|
| 28 |
Francis P. Pankowicz, Mercedes Barzi, Xavier Legras, Leroy Hubert, Tian Mi, Julie A. Tomolonis, Milan Ravishankar, Qin Sun, Diane Yang, Malgorzata Borowiak, Pavel Sumazin, Sarah H. Elsea, Beatrice Bissig-Choisat, Karl-Dimiter Bissig. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nature Communications 2016; 7(1) doi: 10.1038/ncomms12642
|